1Α,20s-Dihydroxyvitamin D3 Interacts with Vitamin D Receptor: Crystal Structure and Route of Chemical Synthesis
Zongtao Lin,Hao Chen,Anna Y. Belorusova,John C. Bollinger,Edith K. Y. Tang,Zorica Janjetovic,Tae-Kang Kim,Zhongzhi Wu,Duane D. Miller,Andrzej T. Slominski,Arnold E. Postlethwaite,Robert C. Tuckey,Natacha Rochel,Wei Li
DOI: https://doi.org/10.1038/s41598-017-10917-7
IF: 4.6
2017-01-01
Scientific Reports
Abstract:1α,20 S -Dihydroxyvitamin D3 [1,20 S (OH) 2 D 3 ], a natural and bioactive vitamin D3 metabolite, was chemically synthesized for the first time. X-ray crystallography analysis of intermediate 15 confirmed its 1α-OH configuration. 1,20 S (OH) 2 D 3 interacts with the vitamin D receptor (VDR), with similar potency to its native ligand, 1α,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] as illustrated by its ability to stimulate translocation of the VDR to the nucleus, stimulate VDRE-reporter activity, regulate VDR downstream genes ( VDR , CYP24A1 , TRPV6 and CYP27B1 ), and inhibit the production of inflammatory markers (IFNγ and IL1β). However, their co-crystal structures revealed differential molecular interactions of the 20 S -OH moiety and the 25-OH moiety to the VDR, which may explain some differences in their biological activities. Furthermore, this study provides a synthetic route for the synthesis of 1,20 S (OH) 2 D 3 using the intermediate 1α,3β-diacetoxypregn-5-en-20-one (3), and provides a molecular and biological basis for the development of 1,20 S (OH) 2 D 3 and its analogs as potential therapeutic agents.